Hologic Inc (NASDAQ:HOLX)
| 21.43 Data as of Jun 17 |  +0.15 / +0.70%Today’s Change | 17.13 Today|||52-Week Range 23.96 | +7.10% Year-to-Date |
Latest HOLX News | Press Releases
| Why This Health Care Play Looks Like a Good Value Jun 14 / MotleyFool.com | Quest and Hologic Extend Ties - Analyst Blog Jun 07 / Zacks.com |
Today’s Trading
| Previous close | 21.28 |
| Today’s open | 21.46 |
| Day’s range | 21.29 - 21.58 |
| Volume | 2,086,239 |
| Average volume (3 months) | 2,681,069 |
| Market cap | $5.8B |
| Dividend yield | -- |
Data as of 4:00pm ET, 06/17/2013
Growth & Valuation
| Earnings growth (last year) | -147.46% |
| Earnings growth (this year) | +11.72% |
| Earnings growth (next 5 years) | +12.10% |
| Revenue growth (last year) | +11.92% |
| P/E ratio | NM |
| Price/Sales | 2.67 |
| Price/Book | 1.92 |
Competitors
Data as of 4:00pm ET, 06/17/2013
Financials
| Next reporting date | August 5, 2013 |
| EPS forecast (this quarter) | $0.37 |
| Annual revenue (last year) | $2.0B |
| Annual profit (last year) | -$73.6M |
| Net profit margin | -3.68% |
Profile
Sector Health Technology |
Industry Medical Specialties |
President, Chief Executive Officer & Director Robert A. Cascella |
CFO, Director & Executive VP-Administration Glenn P. Muir, MBA, CPA |
Corporate headquarters Bedford, Massachusetts |
Forecasts
